Showing results (581-590 of 689) with videos related to

Sort By:
Pageof 69
Circulation|April 10, 2002
Enoxaparin as adjunctive antithrombin therapy for ST-elevation myocardial infarction: results of the ENTIRE-Thrombolysis in Myocardial Infarction (TIMI) 23 TrialElliott M Antman, Hans W Louwerenburg, Hubert F Baars, et al.
Circulation. Cardiovascular Quality and Outcomes|May 24, 2012
Systems of care for ST-segment-elevation myocardial infarction: a report From the American Heart Association's Mission: LifelineJames G Jollis, Christopher B Granger, Timothy D Henry, et al.
Circulation|November 18, 2005
Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 TrialMarc S Sabatine, David A Morrow, Gilles Montalescot, et al.
Journal of the American College of Cardiology|November 6, 2012
Comparison of the prognosis of spontaneous and percutaneous coronary intervention-related myocardial infarctionSergio Leonardi, Laine Thomas, Megan L Neely, et al.
Clinical Trials (London, England)|February 20, 2008
Specific barriers to the conduct of randomized trialsLelia Duley, Karen Antman, Joseph Arena, et al.
American Heart Journal|July 1, 2008
Rationale and design of the Post-MI FREEE trial: a randomized evaluation of first-dollar drug coverage for post-myocardial infarction secondary preventive therapiesNiteesh K Choudhry, Troyen Brennan, Michele Toscano, et al.
Critical Pathways in Cardiology|March 15, 2008
Underutilization of evidence-based medications in acute ST elevation myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 9 RegistryChristopher P Cannon, Maria Cecilia Bahit, J Mark Haugland, et al.
Journal of the American College of Cardiology|September 22, 2018
Edoxaban Versus Warfarin in Latin American Patients With Atrial Fibrillation: The ENGAGE AF-TIMI 48 TrialRamón Corbalán, José Carlos Nicolau, José López-Sendon, et al.
Lancet (London, England)|March 15, 2015
Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trialChristian T Ruff, Robert P Giugliano, Eugene Braunwald, et al.
European Heart Journal|April 5, 2007
Treatment and outcomes of patients with evolving myocardial infarction: experiences from the SYNERGY trialChadwick D Miller, Anindita Banerjee, Kenneth W Mahaffey, et al.
Pageof 69